Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Current Vascular Pharmacology

Volume 10 Issue 6
ISSN: 1570-1611
eISSN: 1875-6212


   All Titles

  Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis
  pp.684-686 (3) Authors: Marcello Arca, Giovanni Pigna, Carla Favoccia

Diabetic dyslipidemia is due to a multiple array of metabolic abnormalities determining a typical phenotype characterized by increased plasma triglycerides, reduced HDL and a preponderance of small, dense LDL. This dyslipidemia, defined as atherogenic dyslipidemia, is thought to be highly responsible for the increased cardiovascular risk in diabetes mellitus. Several lines of evidence indicate that the increased liver production of VLDL is the main underlying defect in atherogenic dyslipidemia. This review will recapitulate the pathophysiological aspects of diabetic dyslipidemia with special focus on the molecular mechanism causing increased liver production of VLDL in diabetic patients. The consequences of atherogenic dyslipidemia on mechanisms of atherogenesis will be also reviewed.

  Keywords: Atherogenic dyslipidemia, VLDL secretion, apoB metabolism, insulin resistance
  Affiliation: Dipartimento di Medicina Interna e Specialita Mediche, Sapienza Universita di Roma Viale del Policlinico, 155- 00161 Rome, Italy.
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers


  Copyright © 1994 - 2015   Bentham Science Publishers